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Abstract. 
 
Mucosa-associated lymphoid tissue (MALT) 
lymphomas are associated with overexpression and 
constitutive activity of bcl10, a caspase recruitment do-
 
main (CARD)-containing protein that activates NF-
 
k
 
B. 
Here, we show that arrangement of overexpressed 
bcl10 protein in cytoplasmic ﬁlaments is essential for 
recruitment of signal transducer molecules-involved 
NF-
 
k
 
B activation. We also show that cytoskeleton ele-
ments regulate bcl10 signaling.
Thus, organized assemblage of proteins in ordered 
structures linked to the cytoskeleton network may rep-
resent a general mechanism for intracellular signaling.
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Introduction
 
Mucosa-associated lymphoid tissue (MALT)
 
1
 
 lymphomas
with t(1;14)(p22;q32) display a recurrent breakpoint up-
stream of 
 
bcl10
 
 that juxtaposes the gene under the control
of the Ig heavy chain enhancer (Willis et al., 1999; Zhang
et al., 1999). As a consequence of this translocation, 
 
bcl10
 
cDNAs from MALT lymphomas are overexpressed and
contain a variety of mutations, mostly consisting of either
nucleotide deletion or insertion, which result in trunca-
tions within or distal to the CARD (Willis et al., 1999;
Zhang et al., 1999). Thus, overexpression of truncated
forms of bcl10, which retain constitutive NF-
 
k
 
B–inducing
activity, transform primary rat embryonic fibroblasts (Wil-
lis et al., 1999). However, the mechanism by which deregu-
lated expression of 
 
bcl10
 
 leads to cellular oncogenesis is
currently not known.
Here, we show that bcl10 protein assemblates in cyto-
plasmic filaments that serve as scaffold for recruitment of
NF-
 
k
 
B–activating signal transduction molecules. Cytocha-
lasin D, a potent inhibitor of actin filament function, disas-
sembles bcl10 filaments and specifically inhibits bcl10-
induced NF-
 
k
 
B activation. Thus, assemblage of bcl10 in
filaments connected to the cytoskeleton network is essen-
tial for bcl10-mediated NF-
 
k
 
B induction.
 
Materials and Methods
 
Cell Culture, Reagents and Luciferase Assay
 
HeLa, HEK 293, and Rat-2 cells were cultured in DME 10% FCS. HeLa
and Rat-2 cells were transfected using lipofectamine (GIBCO BRL); 293
cells were transfected by calcium phosphate precipitation. To assess NF-
 
k
 
B activation, HeLa and Rat-2 cells were transfected with 2 
 
m
 
g of the indi-
cated cDNAs, together with pNF-
 
k
 
B-luc in 12-well plates. Cells were then
lysed and luciferase activity was determined with the Luciferase Assay
System (Promega). A plasmid expressing 
 
b
 
-galactosidase was added to
the transfection mixture for normalization of the efficiency of transfec-
tion. Cytochalasin D was obtained from Sigma Chemical Co.
 
Plamids Construction and Reagents
 
PCR-based random mutagenesis of bcl10 was carried out in the following
reaction buffer: 10 mM Tris-HCl, pH 8, 50 mM KCl, 0.5 mM MnCl
 
2
 
, 125
 
m
 
M dNTPs. Reaction was performed using 2.5 U standard Taq poly-
merase, 200 ng of plasmidic template, and the oligos 5
 
9
 
-AAGAATTC-
CATGGAGCCCACCGCACC (forward) and 5
 
9
 
-AACTCGAGTCATG-
GAAAAGGTTCACAACTGCT (reverse). PCR products were purified
and cloned in pcDNA3 expression vector (Invitrogen) provided with an
HA epitope. The vectors pNF-
 
k
 
B-luc and pCMV-
 
b
 
-gal were from Clon-
tech.
 
Immunofluorescence
 
HeLa cells were grown and transfected in chamber slides. 16 h after trans-
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fection, cells were fixed in 4% paraformaldehyde for 15 min at room tem-
perature and then permeabilized in PBS/0.1% Triton X-100. Primary anti-
bodies were incubated for 30 min in 5% FCS–PBS, followed by several
washes with 5% FCS–PBS, and then incubating for 30 min with secondary
antibody in 5% FCS–PBS. All steps were done at room temperature.
Sources of antibodies and reagents for immunofluorescence were: anti-HA
(Roche Molecular Biochemicals); anti-FLAG and anti–
 
a
 
-actinin (Sigma
Chemical Co.); anti-TRADD and anti-RIP (Santa Cruz).
 
Two-Hybrid Screen and 
 
b
 
-Gal Assays
 
The two-hybrid screening was conducted using the Matchmaker system
(Clontech) according to the manufacturer’s instructions. In brief, yeast
strain HF7c, expressing GAL4-DR4 fused protein, was transformed with
a human peripheral blood leukocyte cDNA library cloned in the pGAD10
vector (Clontech) by lithium acetate/PEG 4000 procedure. 2 
 
3
 
 10
 
6
 
 clones
were analyzed. Transformed yeast were selected on SD/agar plates lack-
ing leucine, tryptophane, and histidine for 5 d at 30
 
8
 
C. Selected colonies
were blotted on filter paper, permeabilized in liquid nitrogen, and placed
on another filter soaked in Z buffer (60 mM Na
 
2
 
HPO
 
4
 
, 40 mM NaH
 
2
 
PO
 
4
 
,
10 mM KCl, 1mM MgSO
 
4
 
, and 37.5 mM 
 
b
 
-mercaptoethanol) containing 1
mM 5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
D
 
-galactoside. Colonies that developed
color were restreaked on selective plates to allow plasmid segregation and
tested again for 
 
b
 
-galactosidase activity. The liquid 
 
b
 
-galactosidase assay
was performed according to the manufacturer’s instructions using CPRG
as substrate.
 
In Vitro Binding and Immunoblot Analysis
 
Recombinant histidine-tagged proteins were made in 
 
Escherichia coli
 
BL21 strain using the pET expression system (Novagen). Proteins were
purified with Ni-NTA agarose beads (Quiagen) and mixed with recombi-
nant 
 
a
 
-actinin (Sigma Chemical Co.) in E1A buffer (50 mM Hepes, 500
nM NaCl, 0.1% NP-40, and 10% glycerol). Samples were incubated for
1–2 h at 4
 
8
 
C, extensively washed by pulse centrifugation with E1A buffer
and resuspended in 40 
 
m
 
l sample buffer. 5 
 
m
 
l of the reaction was loaded
for SDS-PAGE and Western blot analysis.
 
Results and Discussion
 
To determine the cellular localization of oncogenic bcl10,
we transfected HeLa cells with an HA-tagged vector en-
coding the full-length bcl10, and the expressed protein was
detected using a monoclonal anti-HA antibody. The re-
sults in Fig. 1 show that bcl10 exhibits a clear pattern of
discrete and interconnecting cytoplasmic filaments resem-
bling the death-effector filaments (Perez and White, 1998;
Siegel et al., 1998). Similar filaments were observed when
bcl10 was visualized using specific affinity-purified rabbit
antisera raised against a bcl10-derived polypeptide (Fig. 1
Figure 1. Subcellular localization of bcl10. HeLa cells were transfected with mammalian HA-tagged vector, empty (A) or expressing
bcl10 (B). 16 h after transfection, cells were stained with anti-HA mAb, followed by FITC-conjugated anti-mouse IgG. C, Immunoblot
analysis of proteic lysates from 293 cells transfected with FLAG-tagged vector, empty or expressing bcl10. Membranes were probed
with anti-FLAG mAb or with two different anti-bcl10 affinity-purified rabbit antisera generated against the polypeptides Arg58–Glu74
(Ab-1) and Phe125–Lys146 (Ab-2), followed by HRP-conjugated secondary mAb. D, HeLa cells transfected with bcl10 were stained with
anti-bcl10 antisera (Ab-1), followed by FITC-conjugated anti-rabbit IgG. Similar results were obtained when the staining was done with
Ab-2. 
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D). The filaments were not an artifact of the staining pro-
cedure, since competition with the immunogenic peptide
abolished the immunofluorescence (data not shown).
Double-staining experiments indicated that bcl10 fila-
ments partially overlap other cellular filaments, such as tu-
bulin, keratin, and actin (data not shown).
The NH
 
2
 
-terminal region of bcl10 contains a CARD
motif (Costanzo et al., 1999; Koseki et al., 1999; Sriniva-
sula et al., 1999; Thome et al., 1999; Willis et al., 1999; Yan
et al., 1999; Zhang et al., 1999), which is both necessary
and sufficient for NF-
 
k
 
B induction (Costanzo et al., 1999;
Koseki et al., 1999; Willis et al., 1999; Zhang et al., 1999).
To verify whether the CARD was involved in determining
the filamentous arrangement of bcl10, we tested deleted
versions of bcl10 for filament formation. A truncated bcl10
polypeptide (bcl10
 
128-233
 
) that lacks the CARD region
showed a nonfilamentous diffuse distribution, whereas the
CARD alone (bcl10
 
1-127
 
) formed filaments identical to the
full-length protein (Fig. 2 A). Since the CARD of bcl10 re-
tains the NF-
 
k
 
B–inducing activity, these experiments sug-
gested a correlation between filaments formation and
bcl10-mediated NF-
 
k
 
B activation. To further explore this
possibility, we generated the point mutants bcl10(L41Q)
and bcl10(G78R), because mutations of corresponding
 
Figure 2.
 
Mutations in the CARD abolish filament formation and NF-
 
k
 
B activation. A, Fluorescence confocal micrographs of bcl10
mutants. HeLa cells expressing bcl10
 
128-233
 
, bcl10
 
1-127
 
, bcl10(L41Q), and bcl10(G78R) were stained with anti-HA mAb followed by FITC-
conjugated anti-mouse IgG. B, HeLa
cells were cotransfected with pNF-
 
k
 
B-
luc, pCMV-
 
b
 
-gal, and an equal amount
of the indicated bcl10 mutant. Data
represent relative luciferase activity
normalized for 
 
b
 
-galactosidase expres-
sion and is representative of three inde-
pendent triplicate experiments. C,
 
 
 
HeLa
cells expressing bcl10 together with
dominant negative versions of I
 
k
 
B
(right)
 
 
 
or NIK (left) were stained with
anti-HA mAb, followed by FITC-con-
jugated anti-mouse IgG. 
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residues in the CARD of the cell death-inducing proteins,
CED-3 and RAIDD, abrogate their functional activity
(Shaham and Horvitz, 1996; Duan and Dixit, 1997). Al-
though expressed at levels comparable to the wild-type
protein (data not shown), both mutants, bcl10(L41Q) and
bcl10(G78R), did not form filaments and failed in activat-
ing NF-
 
k
 
B (Fig. 2 B).
bcl10 filament formation is not an effect of NF-
 
k
 
B acti-
Figure 3. bcl10 filaments correlate with NF-kB activation. A,
PCR-based randomly mutagenized versions of bcl10 were trans-
fected in HeLa cells and assayed for filament formation and NF-
kB activation as described in Fig. 2. Amino acids in bold repre-
sent sequence identity or conservative substitutions through the
CARD regions of Apaf1, ARC, Raidd, c-IAP-1, c-IAP-2, cardiak,
caspase-1, caspase-2, caspase-4, caspase-5, caspase-9, ced3 and
ced4. (B) bcl10 mutants were scored positive for filament forma-
tion when filaments were detected in .60% of transfected cells;
bcl10 mutants were scored positive for NF-kB activation when
luciferase activity was at least threefold higher than control vec-
tor in two independent triplicate experiments. Similar results
were obtained with an additional 15 mutant versions of bcl10
(data not shown). 
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vation because when bcl10 was cotransfected with domi-
nant negative forms of I
 
k
 
B and NIK, which abrogate
bcl10-induced NF-
 
k
 
B activation (Costanzo et al., 1999;
Koseki et al., 1999; Srinivasula et al., 1999), bcl10 filaments
were formed (Fig. 2 C).
To determine whether bcl10 filaments are unequivocally
linked to NF-
 
k
 
B activation, we generated a panel of ran-
dom mutations in the CARD region of the protein. Mi-
croscopy and functional analysis of these mutants indeed
revealed that only bcl10 mutants still able to form fila-
ments could activate NF-
 
k
 
B (Fig. 3).
Previously, we and others have shown that bcl10 acti-
Figure 4. Recruitment of
TRADD and RIP into bcl10
filaments. A, HeLa cells ex-
pressing bcl10 and FLAG-
tagged TRADD were co-
stained with anti-bcl10,
followed by FITC-conju-
gated anti-rabbit IgG (green
fluorescence) and anti-FLAG
followed by rhodamine-con-
jugated anti-mouse IgG (red
fluorescence). Overlay of the
two channels generate a yel-
low overlapping fluores-
cence. B, HeLa cells un-
treated (left) or transfected
with bcl10 (right), were
stained with anti-TRADD
antibody followed by FITC-
conjugated anti-rabbit IgG.
C, HeLa cells transfected
with HA-tagged bcl10 were
costained with anti-bcl10,
followed by FITC-con-
jugated anti-mouse IgG
(green fluorescence) and
anti-Tradd, followed by
rhodamine-conjugated anti-
rabbit IgG (red fluores-
cence). Overlay of the two
channels generate a yellow
overlapping fluorescence. D,
HeLa cells transiently trans-
fected with bcl10 were
stained with anti-RIP anti-
body, followed by FITC-con-
jugated anti-rabbit IgG. 
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vates NF-
 
k
 
B through a molecular pathway involved in tu-
mor necrosis factor receptor 1 (TNF-R1) signaling (Cos-
tanzo et al., 1999; Koseki et al., 1999; Srinivasula et al.,
1999). To determine whether bcl10 filaments served as
scaffolds for recruitment of signal transduction molecules,
we performed double-staining experiments of bcl10 to-
gether with antibodies against proteins involved in TNF-
RI signaling. Fig. 4 A shows that TRADD, an adapter
molecule that is recruited to TNF-RI complex and signals
NF-
 
k
 
B activation (Hsu et al., 1995), localizes on bcl10 fila-
ments. To determine whether TRADD could be actively
recruited on bcl10 filaments, HeLa cells were left un-
treated or transfected with bcl10 and localization of en-
dogenous TRADD was detected with anti-TRADD anti-
body by confocal microscopy. The results in Fig. 4, B and
C, show that whereas in untransfected cells, endogenous
 
TRADD displays a diffuse cytoplasmic and nuclear distri-
bution, expression of bcl10 results in translocation of cyto-
plasmic TRADD to bcl10 filaments. This observation is
consistent with coprecipitation of TRADD with bcl10
(Costanzo et al., 1999), and implies that only filamentous
organization of bcl10 allows recruitment of TRADD. The
death domain-containing serine/threonine kinase RIP is
essential for TNF-induced NF-
 
k
 
B signaling (Kelliher
et al., 1998) and is recruited to TNF-R1 complex via in-
teraction with TRADD (Hsu et al., 1996). Similarly
to TRADD, whereas in untransfected cells endogenous
RIP displays a diffuse cytoplasmic localization (data not
shown), expression of bcl10 results in translocation of RIP
to bcl10 filaments (Fig. 4 D; and data not shown).
To assess whether cytoskeleton dynamics influence
bcl10 activity, HeLa cells expressing bcl10 were treated
Figure 5. Cytochalasin D disassembles bcl10 filament and bcl10-
induced NF-kB activation. HeLa cells were cultured in presence
of cytochalasin D (20 mM) for the indicated time and bcl10 distri-
bution (A) and NF-kB activation (B) were determined as de-
scribed in Materials and Methods. Data presented in B is repre-
sentative of three independent triplicate experiments. 
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with cytochalasin D, a potent inhibitor of actin filament
function, and bcl10 localization was determined. As shown
in Fig. 5, cytochalasin D disassembles bcl10 filaments
and specifically inhibits bcl10-induced NF-
 
k
 
B activation,
whereas NF-
 
k
 
B activation induced by TNF stimulation or
NIK overexpression is not affected. Thus, assemblage of
bcl10 in filaments is essential for bcl10-mediated NF-
 
k
 
B
induction.
bcl10 filament formation could either reflect an intrin-
sic property of that protein or be ordered via interac-
tions with preexisting filamentous proteins. The observa-
tion that cytochalasin D disassembles bcl10 filaments
prompted us to explore the possibility these filaments
might be organized by CARD-mediated association with
cytoskeletal components. To test for this, we performed a
two-hybrid screen fusing the CARD of bcl10 to the DNA
binding domain of GAL4 and searched a plasmid library
of fusion between the GAL4 transcription activation do-
main and cDNAs from peripheral blood leukocytes. 13 in-
dependent clones were isolated that activated the 
 
b
 
-galac-
tosidase reporter gene when 
 
z
 
2 
 
3 
 
10
 
6
 
 transformants were
analyzed. Restriction mapping and partial sequencing of
these 13 cDNAs revealed that six positive clones had the
same
 
 
 
z
 
2-kb cDNA insert encoding for the polypeptide
Pro
 
355
 
–Leu
 
892
 
 of 
 
a
 
-actinin, a member of the actin-binding
proteins superfamily that is thought to cross-link actin fila-
ments. As summarized in Table I, a library plasmid encod-
ing for Pro
 
355
 
–Leu
 
892
 
 of 
 
a
 
-actinin did not activate 
 
b
 
-galac-
tosidase by itself, when coexpressed with the empty
GAL4BD vector, or with unrelated control plasmids. Con-
versely, it strongly interacted with the CARD of bcl10.
However, both wild-type and mutant forms of bcl10 bind
similarly to 
 
a
 
-actinin in yeast and in vitro (Table I and Fig.
6 A). Together with cytochalasin D experiments, the two-
hybrid data suggest that interaction of bcl10 with cyto-
skeleton components is necessary, but not sufficient for fil-
ament formation.
Next, we tested whether filament formation could result
from bcl10 multimerization. Immunoprecipitation analysis
shown in Fig. 6 B revealed that wild-type bcl10 self-associ-
ates via a CARD-mediated homophilic interaction, how-
ever, both mutants bcl10(L41Q) and bcl10(G78R) did not
dimerize, suggesting that bcl10 filaments result from self-
assembly. Thus, both dimerization of bcl10 and binding to
 
a
 
-actinin are necessary for filament formation and NF-
 
k
 
B
activation.
bcl10 is expressed in many normal tissues and overex-
pression of the gene causes cellular transformation (Willis
et al., 1999; Zhang et al., 1999). Therefore, we tested
whether filamentous organization of bcl10 and deregu-
lated NF-
 
k
 
B activation both derive from disregulated level
of expression of the protein. Indeed, in Rat-2 cells, endog-
 
Table I. Specificity of the Interaction between bcl10 and 
Cytoskeleton Proteins
 
Protein fused to GAL4 domain
 
b
 
-Galactosidase 
filter assay Liquid assay DNA-binding Activating
 
Miller units
 
–
 
a
 
-Actinin White 0.04 
 
6
 
 0.02
Vector
 
a
 
-Actinin White 0.03 
 
6
 
 0.01
pLAM5
 
a
 
-Actinin White 0.03 
 
6
 
 0.01
bcl10
 
a-Actinin Blue 0.40 6 0.03
DR4 a-Actinin White 0.01 6 0.01
Flice a-Actinin White 0.02 6 0.02
Fadd a-Actinin White 0.01 6 0.00
bcl10L41Q a-Actinin Blue 0.32 6 0.04
bcl10G78R a-Actinin Blue 0.44 6 0.02
mut 6 a-Actinin Blue 0.36 6 0.02
mut 9 a-Actinin Blue 0.40 6 0.80
mut 11 a-Actinin Blue 0.24 6 0.03
bcl10 – White 0.01 6 0.00
HF7c cells were cotransformed with vectors encoding for the indicated polypeptides
fused to GAL4 DNA-binding domain and GAL4 transcriptional activation domain.
Filter and liquid assays for b-galactosidase activity are shown. Yeast colonies were
scored as positive when a bright color developed within 2–5 h, a negative colony was
scored when color failed to develop within 12 h. Assays were done for 5–10
independent transformants. 
Figure 6.  A, In vitro binding of bcl10 with a-actinin. Histidine-
tagged bcl10 proteins were purified on agarose beads and mixed
with 5 mg of recombinant a-actinin. Beads were washed, boiled in
SDS-sample buffer, resolved by SDS-PAGE, and transferred on
nitrocellulose membrane subsequently probed with anti–a-acti-
nin, followed by HRP-conjugated secondary mAb. Agarose-immo-
bilized TRAIL served as control for nonspecific binding. A frac-
tion of the reaction mixtures was stained with Coomassie and
aligned to visualize histidine-tagged proteins. B, Mutations in the
CARD abolish bcl10 dimerization. 293 cells were transfected
with the full-length or a truncated CARD-containing version of
bcl10 together with the indicated cDNAs expressed in pCMV-
FLAG. After transfection, samples were immunoprecipitated
with anti-HA mAb and analyzed for coprecipitating proteins by
immunoblotting, followed by probing with anti-FLAG mAb.The Journal of Cell Biology, Volume 148, 2000 1138
enous bcl10 displays a diffuse cytosolic distribution,
whereas overexpression of the gene induces filament for-
mation and NF-kB activation (Fig. 7). These results, how-
ever, do not exclude the possibility that local micro-assem-
bling of the protein may physiologically occur in normal
conditions or after specific stimulation.
Independent evidence suggests that the transforming ca-
pability of bcl10 is the result of a nonreceptor-mediated
NF-kB activation arising from deregulated expression of
the gene (Willis et al., 1999; Zhang et al., 1999). In the
present study, we have shown that organization of bcl10
into ordered structures is essential for NF-kB–inducing ac-
tivity of the protein. Similarly to scaffolding and anchoring
proteins that determine selective activation of mitogen-
activated protein kinases by sequestration and localization
of signaling complexes, filamentous arrangement of bcl10
is required for recruitment of TRADD, and may be es-
sential for local concentration and activation of other
downstream signaling proteins. Hence, as recruitment of
TRADD to TNF-RI complex initiates a signal transduc-
tion pathway leading to NF-kB activation, the same signal-
ing pathway can be activated upon TRADD recruitment
to different cellular compartments.
Cytoskeletal-like shape of bcl10 filaments and direct in-
teraction of bcl10 with cytoskeletal proteins suggest that
cytoskeleton dynamics may regulate bcl10 signaling. In-
deed, activation of the NF-kB transcription factors is di-
rectly influenced by changes in the cytoskeleton network
(Rosette and Karin, 1995). bcl10 filaments resemble the
death-effector filaments, cytoplasmic filaments that se-
quester and activate procaspase zymogens (Perez and White,
1998; Siegel et al., 1998), and similar structures are formed
when the CARD of caspase-2 is overexpressed (Colussi et
al., 1998). Generation of death-effector filaments is essen-
tial for activation of a signaling cascade leading to cellular
apoptosis, and inhibition of filament formation prevents
cell death. Thus, formation of ordered assembly of protein
may represent a general mechanism for receptor-indepen-
dent activation of specific signal transduction pathways.
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